Showing results (51-60 of 93) with videos related to
Sort By:
Pageof 10
Therapeutic Advances in Medical Oncology|August 6, 2020
Apatinib treatment may improve survival outcomes of patients with hepatitis B virus-related sorafenib-resistant hepatocellular carcinomaYingqiang Zhang, Guihua Huang, Hongfei Miao, et al.Frontiers in Oncology|January 1, 2021
Silencing SAPCD2 Represses Proliferation and Lung Metastasis of Fibrosarcoma by Activating Hippo Signaling PathwayBowen Zhu, Yanqin Wu, Lizhi Niu, et al.Journal of Translational Medicine|June 28, 2012
Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in ratsYu Wang, Fan Lian, Jiaping Li, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 26, 2026
Nano-Backpack Engineered Probiotics with Reactive Oxygen Species-Responsive Tungsten Release for Synergistic Therapy of Inflammatory Bowel DiseaseYang Yang, Liucan Wang, Guoqing Chen, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|January 31, 2018
Comparison between microwave ablation and lobectomy for stage I non-small cell lung cancer: a propensity score analysisWang Yao, Mingjian Lu, Wenzhe Fan, et al.La Radiologia Medica|October 14, 2024
Development and validation of survival prediction models for patients with hepatocellular carcinoma treated with transcatheter arterial chemoembolization plus tyrosine kinase inhibitorsKun Huang, Haikuan Liu, Yanqin Wu, et al.Targeted Oncology|October 9, 2014
Combination of individualized local control and target-specific agent to improve unresectable liver cancer managements: a matched case-control studyJiaping Li, Fujun Zhang, Jianyong Yang, et al.Annals of Translational Medicine|November 4, 2021
Interaction between hepatitis B virus infection and the efficacy of camrelizumab in combination with apatinib therapy in patients with hepatocellular carcinoma: a multicenter retrospective cohort studyGuosheng Yuan, Rong Li, Qi Li, et al.Cancer Medicine|March 15, 2022
Prolonged progression-free survival achieved by octreotide LAR plus transarterial embolization in low-to-intermediate grade neuroendocrine tumor liver metastases with high hepatic tumor burdenYiming Liu, Haikuan Liu, Wenchuan Chen, et al.European Radiology|July 31, 2020
The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolizationYingqiang Zhang, Hongfei Miao, Wenlin Xie, et al.Pageof 10